Principal Investigators

    Dr Bradley Turner


    University of Melbourne

    Contact information of lead PI



    Title of project or programme

    SMN immunogene therapy for motor neuron disorders

    Source of funding information

    National Health and Medical Research Council

    Total sum awarded (Euro)

    € 402,170

    Start date of award


    Total duration of award in years



    Research Abstract

    We have designed novel gene therapy agents to treat MND. This therapeutic approach uniquely combines gene therapy agents with antibodies which stimulate motor neuron health and connections to muscle. This project will comprehensively characterise the therapeutic effects of our novel gene therapy agents in MND mice. We predict that our gene therapy complexes will improve motor neuron survival,motor function and lifespan in MND mice.

    Further information available at:

Types: Investments < €500k
Member States: Australia
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF